Mitochondrial transcription factor A regulates BCL2L1 gene expression and is a prognostic factor in serous ovarian cancer

Human mitochondrial transcription factor A functions in both nuclei and mitochondria and regulates cancer cell growth

(2011) Bin Han et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Functional and biological analysis of Bcl-xL expression in human osteosarcoma

(2010) Zhao-Xia Wang et al.   BONE

Clinical usefulness of mitochondrial transcription factor A expression as a predictive marker in colorectal cancer patients treated with FOLFOX

(2010) Yoichiro Yoshida et al.   CANCER SCIENCE

Targeting survivin in cancer: patent review

(2010) Jagat R Kanwar et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Expression of mitochondrial transcription factor A in endometrial carcinomas: clinicopathologic correlations and prognostic significance

(2010) Naoyuki Toki et al.   VIRCHOWS ARCHIV

Angiogenesis and ovarian cancer

(2009) César Gómez-Raposo et al.   Clinical & Translational Oncology

Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy

(2009) M. H. Kang et al.   CLINICAL CANCER RESEARCH

Expression and Clinical Role of Antiapoptotic Proteins of the Bag, Heat Shock, and Bcl-2 Families in Effusions, Primary Tumors, and Solid Metastases in Ovarian Carcinoma

(2009) Mari Bunkholt Elstrand et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium

(2009) Sergio Pecorelli   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

Maintenance of mitochondrial DNA copy number and expression are essential for preservation of mitochondrial function and cell growth

(2007) Jaan-Yeh Jeng et al.   JOURNAL OF CELLULAR BIOCHEMISTRY